FDA Approved Expanded Age Indication For GARDASIL 9 In Males For HPV October 14, 2016 cervical cancer cervical precancers GARDASIL®9 heterosexual males HPV Human Papillomavirus 9-valent Vaccine Merck vulvar cancer +
BRIDION (Sugammadex) Received FDA Approval For The Reversal Of Neuromuscular Blockade Induced By Rocuronium And Vecuronium In Adults Undergoing Surgery October 14, 2016 BRIDION Merck rocuronium bromide sugammadex vecuronium bromide +